One of the out-patient rehab alternatives for people in Gadsden struggling with opioid dependence and addiction is called opioid maintenance therapy. Licensed centers and doctors are certified to administer certain medications to opioid dependent people, many that are opioid-based also and are addictive. In low amounts however, the client does not experience high feelings and also does not experience intense cravings and isn't in opioid withdrawal. Methadone is the first drug used for this sole purpose, but there are a few more choices currently to select from.
Methadone is an opiate and can be taken at an outpatient clinic certified to dispense the drug, that is taken on a daily basis as a pill or liquid. The price of the drug is around $150 a month. Buprenorphine is also an opioid-based drug, and is a pill often taken every other day. But unlike Methadone that can only be administered in highly well-regulated medical centers, Buprenorphine can be and is prescribed and dispensed in doctor's offices. The cost monthly of buprenorphine is approximately $300.00 /month for the generic version of the drug. There is also a version of buprenorphine containing the drug naloxone, which is a med which blocks the effects of opiates. An individual consuming this version of the drug, AKA Suboxone, would find it more difficult to feel high from opioids if they relapsed while taking the drug. It too is taken on a daily basis, and costs about $450 a month. Naltrexone is another medication taken in opioid maintenance therapy, but unlike the other drugs aforementioned it's an opiate blocker and is not an opiate. A person has the choice to take this drug as a monthly shot, and that is called Vivitrol. As an opioid blocker, it prevents someone from feeling high from opioids, and in turn lowers the risk associated with relapse. This daily injection costs in the range of $1000 to $1200 monthly.
There are 1 Alcohol and Drug Rehabilitation Programs offering this service in Gadsden, AL
For All Alcohol and Drug Treatment Programs In Gadsden, Click Here.